BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 15300145)

  • 1. New molecular markers for bladder cancer detection.
    Quek ML; Sanderson K; Daneshmand S; Stein JP
    Curr Opin Urol; 2004 Sep; 14(5):259-64. PubMed ID: 15300145
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of hTERT, KRT7, and survivin in urine for noninvasive detection of bladder cancer using real-time PCR.
    Yahyazadeh R; Bashash D; Ghaffari P; Kord S; Safaroghli-Azar A; Ghaffari SH
    BMC Urol; 2021 Apr; 21(1):64. PubMed ID: 33874920
    [TBL] [Abstract][Full Text] [Related]  

  • 3. New diagnostic strategies in the detection and staging of bladder cancer.
    Jichlinski P
    Curr Opin Urol; 2003 Sep; 13(5):351-5. PubMed ID: 12917510
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of telomerase activity and matrix metalloproteinase-9 in voided urine and bladder wash samples as a useful diagnostic tool for bladder cancer.
    Eissa S; Labib RA; Mourad MS; Kamel K; El-Ahmady O
    Eur Urol; 2003 Dec; 44(6):687-94. PubMed ID: 14644121
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Urinary markers in the everyday diagnosis of bladder cancer.
    Dal Moro F; Valotto C; Guttilla A; Zattoni F
    Urologia; 2013; 80(4):265-75. PubMed ID: 24419920
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Urine cytology. It is still the gold standard for screening?
    Brown FM
    Urol Clin North Am; 2000 Feb; 27(1):25-37. PubMed ID: 10696242
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A prospective evaluation of the diagnostic and potential prognostic utility of urinary human telomerase reverse transcriptase mRNA in patients with bladder cancer.
    Bowles L; Bialkowska-Hobrzanska H; Bukala B; Nott L; Razvi H
    Can J Urol; 2004 Dec; 11(6):2438-44. PubMed ID: 15636669
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Performance characteristics of multiple urinary tumor markers and sample collection techniques in the detection of transitional cell carcinoma of the bladder.
    Bhuiyan J; Akhter J; O'Kane DJ
    Clin Chim Acta; 2003 May; 331(1-2):69-77. PubMed ID: 12691866
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bladder cancer biomarkers: current developments and future implementation.
    Alvarez A; Lokeshwar VB
    Curr Opin Urol; 2007 Sep; 17(5):341-6. PubMed ID: 17762628
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Urine based markers of urological malignancy.
    Konety BR; Getzenberg RH
    J Urol; 2001 Feb; 165(2):600-11. PubMed ID: 11176445
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Detection of urothelial bladder cancer cells in voided urine can be improved by a combination of cytology and standardized microsatellite analysis.
    Wild PJ; Fuchs T; Stoehr R; Zimmermann D; Frigerio S; Padberg B; Steiner I; Zwarthoff EC; Burger M; Denzinger S; Hofstaedter F; Kristiansen G; Hermanns T; Seifert HH; Provenzano M; Sulser T; Roth V; Buhmann JM; Moch H; Hartmann A
    Cancer Epidemiol Biomarkers Prev; 2009 Jun; 18(6):1798-806. PubMed ID: 19454613
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sensitivity and specificity of NMP-22, telomerase, and BTA in the detection of human bladder cancer.
    Landman J; Chang Y; Kavaler E; Droller MJ; Liu BC
    Urology; 1998 Sep; 52(3):398-402. PubMed ID: 9730450
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Optimal Trial Design for Studying Urinary Markers in Bladder Cancer: A Collaborative Review.
    Lotan Y; Black PC; Caba L; Chang SS; Cookson MS; Daneshmand S; Kamat AM; McKiernan JM; Pruthi RS; Ritch CR; Steinberg GD; Svatek RS; Zwarthoff EC
    Eur Urol Oncol; 2018 Aug; 1(3):223-230. PubMed ID: 31102625
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Relevance of urine telomerase in the diagnosis of bladder cancer.
    Sanchini MA; Gunelli R; Nanni O; Bravaccini S; Fabbri C; Sermasi A; Bercovich E; Ravaioli A; Amadori D; Calistri D
    JAMA; 2005 Oct; 294(16):2052-6. PubMed ID: 16249419
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Current concepts of tumor markers in bladder cancer.
    Droller MJ
    Urol Clin North Am; 2002 Feb; 29(1):229-34. PubMed ID: 12109349
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Urine-based biomarkers for the early detection and surveillance of non-muscle invasive bladder cancer.
    Herman MP; Svatek RS; Lotan Y; Karakiewizc PI; Shariat SF
    Minerva Urol Nefrol; 2008 Dec; 60(4):217-35. PubMed ID: 18923359
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Current Use and Promise of Urinary Markers for Urothelial Cancer.
    Tabayoyong W; Kamat AM
    Curr Urol Rep; 2018 Oct; 19(12):96. PubMed ID: 30328534
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Urinary markers of bladder carcinoma.
    Dey P
    Clin Chim Acta; 2004 Feb; 340(1-2):57-65. PubMed ID: 14734196
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bladder cancer. II. Molecular aspects and diagnosis.
    Kausch I; Böhle A
    Eur Urol; 2001 May; 39(5):498-506. PubMed ID: 11464029
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunocyt test improves the diagnostic accuracy of urinary cytology: results of a French multicenter study.
    Pfister C; Chautard D; Devonec M; Perrin P; Chopin D; Rischmann P; Bouchot O; Beurton D; Coulange C; Rambeaud JJ
    J Urol; 2003 Mar; 169(3):921-4. PubMed ID: 12576813
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.